The study was carried out in this area and was approved by the Institutional Review Board (IRB) of the Federal University of away from the Department of Family Planning. In this study, the study participants were recruited from January to March 2013 in a referral from the University Hospital of the Federal University away from the Department of Family Planning. Inclusion criteria included: a diagnosis of ophthalmic malignancy according to the ICD-10 criteria (defined as ophthalmic malignant syndrome or ophthalmic retinal neoplasm, which has been reported by a tertiary care doctor) in the past 6 months. Exclusion criteria included: history of ophthalmic malignancy in the past 6 months, a history of systemic or systemic allergy to any of the above mentioned drugs, use of any of the above mentioned drugs in the past 6 months, the use of any of the above mentioned drugs in the past 6 months, and previous history of ocular or glaucoma or ocular allergy. Patients who could be eligible for the study were selected and included: pregnant women who had received a diagnosis of ophthalmic malignancy before the study; women who had an ophthalmic risk factor (eg, diabetes, history of smoking or use of medications). Patients who could not be identified by their first contact with the patients were excluded.
The primary objective of the study was to evaluate whether the use of oral contraceptive (OC) progestogen (Provera® or Letrozole®) could cause significant ocular events in the presence of pregnancy. The secondary objective was to evaluate the risk of ocular events in men who used OC progestogen (Provera®) in the presence of pregnancy. The study population consisted of women who were diagnosed as having ophthalmic malignancy from the date of their first contact with the patients. The participants were asked to complete an oral contraception questionnaire for a follow up period of 6 months, including information on all their personal and family medical and medical history. The participants were asked to report any ocular events that were suspected of occurring before their first contact with the patients. The study participants were also asked to report any side effects that occurred while using OC progestogen (Provera® or Letrozole®). The participants were also asked to report any adverse reactions related to the use of OC progestogen (Provera® or Letrozole®) in the presence of pregnancy. All participants were asked to return the informed consent form to their primary care physician or psychiatrist at the first follow up visit (in the absence of any other reason, the participant was not asked to return the informed consent form for the follow up visit).The Ethics Committee for the Federal University away from the Department of Family Planning in the Faculty of Medicine at the National University of General Hospital in Cape Town approved the study protocol. The study was approved by the IRB, and all participants had been informed about the study. Informed consent was obtained from all study participants before participation. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and its amendments and Good Clinical Practice. The study protocol was approved by the Ethics Committee for the Federal University away from the Department of Family Planning and the National University of General Hospital in Cape Town and the Institutional Review Board (IRB) of the Federal University away from the Department of Family Planning. No other relevant information was disclosed during the study.Ethical Committee for the Federal University away from the Department of Family PlanningSold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$31.50
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Protein(s)v. Contains 2% MgNope, 30
Mg(2.5%), Pg(1.5%)
Nebivolol, 40
Contains Sodium (E2) 40
Also contains: Potassium 40
Necessary Component
Contains 30% Sodium
Also contains: Potassium 30
Medicine RecommendationsThis product requires a valid Australian script.
This product may cause some side effects. If you experience any of these symptoms, stop taking this prescription and contact your doctor or pharmacist.
Healthylife does not cover all possible side effects. If you have a medical problem could you please tell us about it?
Healthylife is not able to provide specific information about side effects. If you are experiencing a medical problem could you please speak to your doctor or pharmacist.
Side effects may include:
All side effects may include mild to moderate side effects that may disappear within a few hours. If you experience more than mild side effects (e.g. nausea, vomiting, lightheadedness, loss of appetite, or weight loss, hallucinations, hearing voices), you may experience more severe side effects. If you experience severe side effects (see above), you should talk to your doctor or pharmacist.
Medicine Info PackagesThis is a comprehensive list of all prescription drugs, including prescription drugs, over-the-counter drugs and dietary supplements. Each prescription is reviewed by the responsible healthcare professional and isoegelbth is not intended for all types of purposes.
Each prescription is reviewed by the responsible healthcare professional and is reviewed by the licensed healthcare professionals who are authorized to do so. Regulated professionals are not allowed to prescribe here.
This product requires a prescription.
Regulated professionals are allowed to prescribe here, but only on the recommendation of a licensed healthcare professional who is allowed to prescribe here. If you have been prescribed a Regulated Drug, speak to your doctor or pharmacist about why you have been prescribed a Regulated Drug.
Note: Regulated professionals are not allowed to prescribe here.
Depo-Provera Injection is a medication that is used to prevent pregnancy. It is available in 150 mg and 300 mg doses. It is a combination medication that contains a medication that prevents pregnancy and a medication that contains a hormone that stops pregnancy. Depo-Provera Injection is a form of a hormone that has been shown to prevent pregnancy. It works by helping to slow down the process of getting pregnant, which can be dangerous and may result in the release of an egg from the ovary. It also prevents ovulation by stopping the ovaries from releasing eggs, which can increase the risk of miscarriage and other health problems.
Depo-Provera Injection is a form of birth control that is taken every day during the fertile years. It is most effective when combined with a healthy diet and regular exercise.
The most common side effects of Depo-Provera Injection include nausea, vomiting, dizziness, headache, and breast tenderness. These side effects are usually mild and temporary. However, some women may experience more serious side effects such as swelling of the face, lips, or eyes, unusual bleeding or bruising, severe pain, or yellowing of the skin or eyes. It is important to talk to a doctor if any side effects become bothersome or last while taking Depo-Provera Injection.
Depo-Provera Injection should only be used by women who are planning to become pregnant. It should be used only if the benefits outweigh the risks, and it is important to follow the instructions provided by a doctor. Taking Depo-Provera Injection with other medications that can delay the process of getting pregnant may lead to side effects such as ovarian hyperstimulation syndrome (OHSS), which can cause severe abdominal pain, vomiting, irregular heartbeat, or other serious complications.
Read More About The Use Of Depo-Provera Injection And Contraceptive ThemedsIf any of these side effects worsen or last for a longer period of time, contact your doctor immediately. Do not stop using the medication without consulting a doctor.
Yes, Depo-Provera Injection is a medication used to prevent pregnancy. It is a form of birth control that is taken every day during the fertile years. It works by stopping the ovaries from releasing eggs, which can be fertilised and release an egg. It also prevents ovulation by stopping the ovaries from releasing eggs, which can increase the chance of pregnancy.
The most common side effects of Depo-Provera Injection include nausea, vomiting, dizziness, headache, breast tenderness, and dark urine.
Depo-Provera Injection is a contraceptive injection that is used to prevent pregnancy.
Save30%
Original price$-$£33.50
Current price
SKU00009-0746-30
Progestogen Depo-Provera 150mg Injectionis a contraceptive injection containing medroxyprogesterone acetate (MPA) for the contraception method of Depo-Medroxyprogesterone acetate (MPA). It is injected into the uterus of pregnant mares after a period has been due. It is given in low doses every other month. Contraceptive methods of Depo-Medroxyprogesterone acetate (MPA) include:
Contraceptive injection information:
The price of Depo-Provera 150mg Injection is:
Depo-Medroxyprogesterone acetate (MPA) is a hormonal contraceptive that may help prevent pregnancy in women who are or may become pregnant and in women who are not using it. It may also help prevent pregnancy in women who are or may become pregnant and in women who are not using it. Depo-Medroxyprogesterone acetate (MPA) can prevent pregnancy by stopping the production of the female hormone estrogen. It also may increase the risk of irregular periods and acne.
Read More More Need CallDepo-Medroxyprogesterone acetate (MPA) has been used for decades to help prevent pregnancy.